Clinical Trial Update: Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study evaluating decitabine and valproic acid in relapsed/refractory leukemia or myelodysplastic syndromes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: COMPLETED